(Q34042624)

English

Beta-lactamase inhibitor combinations with extended-spectrum penicillins: factors influencing antibacterial activity against enterobacteriaceae and Pseudomonas aeruginosa

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

Europe PubMed Central

Beta-lactamase inhibitor combinations with extended-spectrum penicillins: factors influencing antibacterial activity against enterobacteriaceae and Pseudomonas aeruginosa (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Enterobacteriaceae

0 references

Pseudomonas aeruginosa

1 reference

based on heuristic

inferred from title

author name string

Lister PD

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

1 September 2000

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

9 Pt 2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

213S-218S; discussion 224S-228S

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

beta-Lactamases of gram-negative bacteria: new challenges for new drugs

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.14.213S.35045

21 January 2018

beta-Lactam resistance in gram-negative bacteria: global trends and clinical impact

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.14.213S.35045

21 January 2018

Penicillinase Synthesis Controlled By Infectious R Factors In Enterobacteriaceae

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.14.213S.35045

21 January 2018

Penicillinase-producing Gonococci in Liverpool

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.14.213S.35045

21 January 2018

Letter: Penicillinase production by Haemophilus influenzae.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.14.213S.35045

21 January 2018

Nitroimidazole drugs-action and resistance mechanisms I. Mechanism of action

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.14.213S.35045

21 January 2018

CP-45,899, a Beta-Lactamase Inhibitor That Extends the Antibacterial Spectrum of Beta-Lactams: Initial Bacteriological Characterization

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.14.213S.35045

21 January 2018

Beta-lactamase inhibitors from laboratory to clinic

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.14.213S.35045

21 January 2018

Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.14.213S.35045

21 January 2018

Beta-lactamase production in members of the family Enterobacteriaceae and resistance to beta-lactam-enzyme inhibitor combinations

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.14.213S.35045

21 January 2018

Diffusion of beta-lactam antibiotics through the porin channels of Escherichia coli K-12

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.14.213S.35045

21 January 2018

Kinetic interactions of tazobactam with beta-lactamases from all major structural classes

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.14.213S.35045

21 January 2018

Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 beta-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.14.213S.35045

21 January 2018

Combined Activity of Clavulanic Acid and Ticarcillin Against Ticarcillin-Resistant, Gram-Negative Bacilli

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.14.213S.35045

21 January 2018

Antimicrobial resistance with focus on beta-lactam resistance in gram-negative bacilli

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.14.213S.35045

21 January 2018

Interactions of tazobactam and clavulanate with inducibly- and constitutively-expressed Class I beta-lactamases.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.14.213S.35045

21 January 2018

Rapid emergence of resistance in Pseudomonas aeruginosa in cystic fibrosis patients due to in-vivo selection of stable partially derepressed beta-lactamase producing strains

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.14.213S.35045

21 January 2018

Diverse potential of beta-lactamase inhibitors to induce class I enzymes

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.14.213S.35045

21 January 2018

Identifiers

10.1592/PHCO.20.14.213S.35045

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34042624&oldid=1794466863"